Current management of advanced resectable oral cavity squamous cell carcinoma

Clinical and Experimental Otorhinolaryngology

Volumn 4, Issue 1, 2011, Pages 1-10

  Ow, Thomas J ^a   Myers, Jeffrey N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chemotherapy; Head and neck neoplasms; Oral cancer; Radiotherapy; Surgery; Treatment

Indexed keywords

EID: 79953228876     PISSN: 19768710     EISSN: 20050720     Source Type: Journal    
DOI: 10.3342/ceo.2011.4.1.1     Document Type: Review

References (105)

1. Jemal A, Siegel R, Xu J, Ward E., Cancer statistics, 2010. CA Cancer J Clin. 2010 Sep-Oct;60 (5):277-300.
2. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001 Sep;2(9):533-43.
3. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
4. Shah JP. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. Am J Surg. 1990 Oct;160(4):405-9.
5. Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer. 1972 Jun;29(6):1446-9.
6. Schuller DE, McGuirt WF, McCabe BF, Young D. The prognostic significance of metastatic cervical lymph nodes. Laryngoscope. 1980 Apr;90(4):557-70.
7. Kowalski LP, Bagietto R, Lara JR, Santos RL, Silva JF Jr, Magrin J. Prognostic significance of the distribution of neck node metastasis from oral carcinoma. Head Neck. 2000 May;22(3):207-14.
8. Layland MK, Sessions DG, Lenox J., The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. Laryngoscope. 2005 Apr;115(4):629-39.
9. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004 May 6;350(19):1945-52.
10. Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 2005 Oct;27(10):843-50.
11. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004 May 6;350(19):1937-44.
12. Hashibe M, Brennan P, Chuang SC, Boccia S, Castellsague X, Chen C, et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):541-50.
13. Rodu B, Jansson C. Smokeless tobacco and oral cancer: a review of the risks and determinants. Crit Rev Oral Biol Med. 2004 Sep 1; 15(5):252-63.
14. Nair U, Bartsch H, Nair J. Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanisms. Mutagenesis. 2004 Jul;19(4): 251-62.
15. Ha PK, Califano JA. The role of human papillomavirus in oral carcinogenesis. Crit Rev Oral Biol Med. 2004 Jul 1;15(4):188-96.
16. Pintos J, Black MJ, Sadeghi N, Ghadirian P, Zeitouni AG, Viscidi RP, et al. Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada. Oral Oncol. 2008 Mar;44 (3):242-50.
17. Byers RM, Wolf PF, Ballantyne AJ. Rationale for elective modified neck dissection. Head Neck Surg. 1988 Jan-Feb;10(3):160-7.
18. Spiro RH, Spiro JD, Strong EW. Surgical approach to squamous carcinoma confined to the tongue and the floor of the mouth. Head Neck Surg. 1986 Sep-Oct;9(1):27-31.
19. Vidiri A, Guerrisi A, Pellini R, Manciocco V, Covello R, Mattioni O, et al. Multi-detector row computed tomography (MDCT) and magnetic resonance imaging (MRI) in the evaluation of the mandibular invasion by squamous cell carcinomas (SCC) of the oral cavity: correlation with pathological data. J Exp Clin Cancer Res. 2010 Jun 17;29:73.
20. Pons Y, Ukkola-Pons E, Clément P, Gauthier J, Conessa C. Rele vance of 5 different imaging signs in the evaluation of carotid artery invasion by cervical lymphadenopathy in head and neck squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 May;109(5):775-8.
21. Carvalho P, Baldwin D, Carter R, Parsons C. Accuracy of CT in detecting squamous carcinoma metastases in cervical lymph nodes. Clin Radiol. 1991 Aug;44(2):79-81.
22. Yousem DM, Som PM, Hackney DB, Schwaibold F, Hendrix RA., Central nodal necrosis and extracapsular neoplastic spread in cervical lymph nodes: MR imaging versus CT. Radiology. 1992 Mar; 182(3):753-9.
23. Lam P, Au-Yeung KM, Cheng PW, Wei WI, Yuen AP, Trendell-Smith N, et al. Correlating MRI and histologic tumor thickness in the assessment of oral tongue cancer. AJR Am J Roentgenol. 2004 Mar; 182(3):803-8.
24. Gandhi MR, Panizza B, Kennedy D. Detecting and defining the anatomic extent of large nerve perineural spread of malignancy: comparing "targeted" MRI with the histologic findings following surgery. Head Neck. 2010 Jul 19 [Epub]. DOI: 10.1002/hed.21470.
25. Furukawa MK, Furukawa M. Diagnosis of lymph node metastases of head and neck cancer and evaluation of effects of chemoradiotherapy using ultrasonography. Int J Clin Oncol. 2010 Feb;15(1): 23-32.
26. Hwang HS, Perez DA, Orloff LA. Comparison of positron emission tomography/computed tomography imaging and ultrasound in staging and surveillance of head and neck and thyroid cancer. Laryngoscope. 2009 Oct;119(10):1958-65.
27. Wensing BM, Merkx MA, De Wilde PC, Marres HA, Van den Hoogen FJ. Assessment of preoperative ultrasonography of the neck and elective neck dissection in patients with oral squamous cell carcinoma. Oral Oncol. 2010 Feb;46(2):87-91.
28. Yao M, Luo P, Hoffman HT, Chang K, Graham MM, Menda Y, et al. Pathology and FDG PET correlation of residual lymph nodes in head and neck cancer after radiation treatment. Am J Clin Oncol. 2007 Jun;30(3):264-70.
29. Yao M, Smith RB, Hoffman HT, Funk GF, Lu M, Menda Y, et al. Clinical significance of postradiotherapy [18F]-fluorodeoxyglucose positron emission tomography imaging in management of headand- neck cancer-a long-term outcome report. Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):9-14.
30. Uyl-de Groot CA, Senft A, de Bree R, Leemans CR, Hoekstra OS. Chest CT and whole-body 18F-FDG PET are cost-effective in screening for distant metastases in head and neck cancer patients. J Nucl Med. 2010 Feb;51(2):176-82.
31. Lonneux M, Hamoir M, Reychler H, Maingon P, Duvillard C, Calais G, et al. Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study. J Clin Oncol. 2010 Mar 1;28(7):1190-5.
32. de Souza JA, Cohen EE. [18F]Fluorodeoxyglucose positron emission tomography in the initial staging of squamous cell carcinoma of the head and neck: promise, evidence, and reality. J Clin Oncol. 2010 Oct 1;28(28):e516.
33. Rodgers LW Jr, Stringer SP, Mendenhall WM, Parsons JT, Cassisi NJ, Million RR. Management of squamous cell carcinoma of the floor of mouth. Head Neck. 1993 Jan-Feb;15(1):16-9.
34. Patel RS, Dirven R, Clark JR, Swinson BD, Gao K, O'Brien CJ. The prognostic impact of extent of bone invasion and extent of bone resection in oral carcinoma. Laryngoscope. 2008 May;118(5):780-5.
35. Cilento BW, Izzard M, Weymuller EA, Futran N. Comparison of approaches for oral cavity cancer resection: lip-split versus visor flap. Otolaryngol Head Neck Surg. 2007 Sep;137(3):428-32.
36. Mehanna P, Devine J, McMahon J., Lip split and mandibulotomy modifications. Br J Oral Maxillofac Surg. 2010 Jun;48(4):314-5.
37. Devine JC, Rogers SN, McNally D, Brown JS, Vaughan ED. A comparison of aesthetic, functional and patient subjective outcomes following lip-split mandibulotomy and mandibular lingual releasing access procedures. Int J Oral Maxillofac Surg. 2001 Jun;30(3): 199-204.
38. Crile G. On the surgical treatment of cancer of the head and neck: with a summary of one hundred and twenty-one operations performed upon one hunred and five patients. Trans South Surg Gynecol Assoc. 1905;18:108-27.
39. Martin H. The case for prophylactic neck dissection: 1951. CA Cancer J Clin. 1990 Jul-Aug;40(4):245-51.
40. Martin H. Radical neck dissection. Clin Symp. 1961 Oct-Dec;13: 103-20.
41. Ferlito A, Rinaldo A, Robbins KT, Silver CE. Neck dissection: past, present and future? J Laryngol Otol. 2006 Feb;120(2):87-92.
42. Bocca E, Pignataro O, Oldini C, Cappa C. Functional neck dissection: an evaluation and review of 843 cases. Laryngoscope. 1984 Jul;94(7):942-5.
43. Bocca E, Pignataro O. A conservation technique in radical neck dissection. Ann Otol Rhinol Laryngol. 1967 Dec;76(5):975-87.
44. Schiff BA, Roberts DB, El-Naggar A, Garden AS, Myers JN. Selective vs modified radical neck dissection and postoperative radiotherapy vs observation in the treatment of squamous cell carcinoma of the oral tongue. Arch Otolaryngol Head Neck Surg. 2005 Oct;131(10):874-8.
45. Shepard PM, Olson J, Harari PM, Leverson G, Hartig GK. Therapeutic selective neck dissection outcomes. Otolaryngol Head Neck Surg. 2010 May;142(5):741-6.
46. Byers RM. Modified neck dissection: a study of 967 cases from 1970 to 1980. Am J Surg. 1985 Oct;150(4):414-21.
47. Byers RM, Clayman GL, McGill D, Andrews T, Kare RP, Roberts DB, et al. Selective neck dissections for squamous carcinoma of the upper aerodigestive tract: patterns of regional failure. Head Neck. 1999 Sep;21(6):499-505.
48. Spiro RH, Huvos AG, Wong GY, Spiro JD, Gnecco CA, Strong EW. Predictive value of tumor thickness in squamous carcinoma confined to the tongue and floor of the mouth. Am J Surg. 1986 Oct; 152(4):345-50.
49. Byers RM. A word of caution: the skip metastases. Head Neck. 1995 Jul-Aug;17 (4):359-60.
50. Kowalski LP, Bagietto R, Lara JR, Santos RL, Tagawa EK, Santos IR. Factors influencing contralateral lymph node metastasis from oral carcinoma. Head Neck.1999 Mar;21(2):104-10.
51. Weiss KL, Wax MK, Haydon RC 3rd, Kaufman HH, Hurst MK., Intracranial pressure changes during bilateral radical neck dissections. Head Neck. 1993 Nov-Dec;15(6):546-52.
52. Marks SC, Jaques DA, Hirata RM, Saunders JR Jr., Blindness following bilateral radical neck dissection. Head Neck. 1990 Jul-Aug; 12(4):342-5.
53. Giuliano AE, Haigh PI, Brennan MB, Hansen NM, Kelley MC, Ye W, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol. 2000 Jul;18(13):2553-9.
54. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006 Sep 8;355(13):1307-17.
55. Ross GL, Soutar DS, Gordon MacDonald D, Shoaib T, Camilleri I, Roberton AG, et al. Sentinel node biopsy in head and neck cancer: preliminary results of a multicenter trial. Ann Surg Oncol. 2004 Jul;11(7):690-6.
56. Civantos FJ, Zitsch RP, Schuller DE, Agrawal A, Smith RB, Nason R, et al. Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial. J Clin Oncol. 2010 Mar 10; 28(8):1395-400.
57. Cooper JS, Pajak TF, Forastiere A, Jacobs J, Fu KK, Ang KK, et al. Precisely defining high-risk operable head and neck tumors based on RTOG #85-03 and #88-24: targets for postoperative radiochemotherapy? Head Neck. 1998 Oct;20(7):588-94.
58. Ang KK, Trotti A, Brown BW, Garden AS, Foote RL, Morrison WH, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):571-8.
59. Johnson JT, Barnes EL, Myers EN, Schramm VL Jr, Borochovitz D, Sigler BA. The extracapsular spread of tumors in cervical node metastasis. Arch Otolaryngol. 1981 Dec;107(12):725-9.
60. Soutar DS, Scheker LR, Tanner NS, McGregor IA. The radial forearm flap: a versatile method for intra-oral reconstruction. Br J Plast Surg. 1983 Jan;36(1):1-8.
61. Urken ML, Buchbinder D, Weinberg H, Vickery C, Sheiner A, Parker R, et al. Functional evaluation following microvascular oromandibular reconstruction of the oral cancer patient: a comparative study of reconstructed and nonreconstructed patients. Laryngoscope. 1991 Sep;101(9):935-50.
62. Hsiao HT, Leu YS, Lin CC. Tongue reconstruction with free radial forearm flap after hemiglossectomy: a functional assessment. J Reconstr Microsurg. 2003 Apr;19(3):137-42.
63. Su WF, Hsia YJ, Chang YC, Chen SG, Sheng H. Functional comparison after reconstruction with a radial forearm free flap or a pectoralis major flap for cancer of the tongue. Otolaryngol Head Neck Surg. 2003 Mar;128(3):412-8.
64. de Bree R, Rinaldo A, Genden EM, Suarez C, Rodrigo JP, Fagan JJ, et al. Modern reconstruction techniques for oral and pharyngeal defects after tumor resection. Eur Arch Otorhinolaryngol. 2008;265(1):1-9.
65. de Vicente JC, de Villalain L, Torre A, Pena I. Microvascular free tissue transfer for tongue reconstruction after hemiglossectomy: a functional assessment of radial forearm versus anterolateral thigh flap. J Oral Maxillofac Surg. 2008 Nov;66(11):2270-5.
66. Vartanian JG, Magrin J, Kowalski LP. Total glossectomy in the organ preservation era. Curr Opin Otolaryngol Head Neck Surg. 2010 Apr;18(2):95-100.
67. Yun IS, Lee DW, Lee WJ, Lew DH, Choi EC, Rah DK. Correlation of neotongue volume changes with functional outcomes after longterm follow-up of total glossectomy. J Craniofac Surg. 2010 Jan; 21(1):111-6
68. Haughey BH, Fredrickson JM. The latissimus dorsi donor site: current use in head and neck reconstruction. Arch Otolaryngol Head Neck Surg. 1991 Oct;117(10):1129-34.
69. Curtis DA, Plesh O, Miller AJ, Curtis TA, Sharma A, Schweitzer R, et al. A comparison of masticatory function in patients with or without reconstruction of the mandible. Head Neck. 1997 Jul; 19(4):287-96.
70. Futran ND, Haller JR. Considerations for free-flap reconstruction of the hard palate. Arch Otolaryngol Head Neck Surg. 1999 Jun; 125(6):665-9.
71. Hanasono MM, Skoracki RJ. The omega-shaped fibula osteocutaneous free flap for reconstruction of extensive midfacial defects. Plast Reconstr Surg. 2010 Apr;125 (4):160e-162e.
72. Moreno MA, Skoracki RJ, Hanna EY, Hanasono MM. Microvascular free flap reconstruction versus palatal obturation for maxillectomy defects. Head Neck. 2010 Jul;32(7):860-8.
73. Okay DJ, Genden E, Buchbinder D, Urken M. Prosthodontic guidelines for surgical reconstruction of the maxilla: a classification system of defects. J Prosthet Dent. 2001 Oct;86(4):352-63.
74. Lundahl RE, Foote RL, Bonner JA, Suman VJ, Lewis JE, Kasperbauer JL, et al. Combined neck dissection and postoperative radiation therapy in the management of the high-risk neck: a matchedpair analysis. Int J Radiat Oncol Biol Phys. 1998 Feb 1;40 (3):529-34.
75. Huang DT, Johnson CR, Schmidt-Ullrich R, Grimes M. Postoperative radiotherapy in head and neck carcinoma with extracapsular lymph node extension and/or positive resection margins: a comparative study. Int J Radiat Oncol Biol Phys. 1992;23(4):737-42.
76. Hinerman RW, Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Villaret DB. Postoperative irradiation for squamous cell carcinoma of the oral cavity: 35-year experience. Head Neck. 2004 Nov; 26(11):984-94.
77. Kao J, Lavaf A, Teng MS, Huang D, Genden EM. Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage. Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):362-70.
78. Lavaf A, Genden EM, Cesaretti JA, Packer S, Kao J. Adjuvant radiotherapy improves overall survival for patients with lymph nodepositive head and neck squamous cell carcinoma. Cancer. 2008 Feb 1;112(3):535-43.
79. Amdur RJ, Parsons JT, Mendenhall WM, Million RR, Stringer SP, Cassisi NJ. Postoperative irradiation for squamous cell carcinoma of the head and neck: an analysis of treatment results and complications. Int J Radiat Oncol Biol Phys. 1989 Jan;16(1):25-36.
80. Dinshaw KA, Agarwal JP, Laskar SG, Gupta T, Shrivastava SK, Cruz AD. Head and neck squamous cell carcinoma: the role of post-operative adjuvant radiotherapy. J Surg Oncol. 2005 Jul 1; 91(1):48-55.
81. Cozzi L, Fogliata A, Bolsi A, Nicolini G, Bernier J. Three-dimensional conformal vs. intensity-modulated radiotherapy in headand- neck cancer patients: comparative analysis of dosimetric and technical parameters. Int J Radiat Oncol Biol Phys. 2004 Feb 1; 58(2):617-24.
82. Garden AS, Morrison WH, Rosenthal DI, Chao KS, Ang KK. Target coverage for head and neck cancers treated with IMRT: review of clinical experiences. Semin Radiat Oncol. 2004 Apr;14(2):103-9.
83. Yao M, Chang K, Funk GF, Lu H, Tan H, Wacha J, et al. The failure patterns of oral cavity squamous cell carcinoma after intensitymodulated radiotherapy-the university of iowa experience. Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1332-41.
84. Chen WC, Hwang TZ, Wang WH, Lu CH, Chen CC, Chen CM, et al. Comparison between conventional and intensity-modulated post-operative radiotherapy for stage III and IV oral cavity cancer in terms of treatment results and toxicity. Oral Oncol. 2009 Jun; 45(6):505-10.
85. Chen AM, Farwell DG, Luu Q, Chen LM, Vijayakumar S, Purdy JA. Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2010 Jul 23 [Epub]. Doi:10.1016/j.ijrobp.2010.04.011.
86. Chen AM, Farwell DG, Luu Q, Chen LM, Vijayakumar S, Purdy JA. Misses and near-misses after postoperative radiation therapy for head and neck cancer: comparison of IMRT and non-IMRT techniques in the CT-simulation era. Head Neck.2010 Nov;32(11): 1452-9.
87. Roe JW, Carding PN, Dwivedi RC, Kazi RA, Rhys-Evans PH, Harrington KJ, et al. Swallowing outcomes following Intensity Modulated Radiation Therapy (IMRT) for head & neck cancer: a systematic review. Oral Oncol. 2010 Oct;46(10):727-33.
88. Huguenin P, Beer KT, Allal A, Rufibach K, Friedli C, Davis JB, et al. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy. J Clin Oncol. 2004 Dec 1;22(23):4665-73.
89. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006 Feb 9;354(6):567-78.
90. Rosenthal DI, Harris J, Forastiere AA, Weber RS, Ridge JA, Myers JN, et al. Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell carcinoma:report of the phase II trial RTOG 0024. J Clin Oncol. 2009 Oct 1;27(28): 4727-32.
91. Goodwin WJ Jr. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when the ends justify the means? Laryngoscope. 2000 Mar;110(3 Pt 2 Suppl 93):1-18.
92. Kostrzewa JP, Lancaster WP, Iseli TA, Desmond RA, Carroll WR, Rosenthal EL. Outcomes of salvage surgery with free flap reconstruction for recurrent oral and oropharyngeal cancer. Laryngoscope. 2010 Feb;120(2):267-72.
93. Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, et al. Salvage therapy in relapsed squamous cell carcinoma of the oral cavity: how and when? Cancer. 2008 Jan 1;112(1):94-103.
94. Kowalski LP. Results of salvage treatment of the neck in patients with oral cancer. Arch Otolaryngol Head Neck Surg. 2002 Jan; 128(1):58-62.
95. Sklenicka S, Gardiner S, Dierks EJ, Potter BE, Bell RB. Survival analysis and risk factors for recurrence in oral squamous cell carcinoma: does surgical salvage affect outcome? J Oral Maxillofac Surg. 2010 Jun;68(6):1270-5.
96. Iseli TA, Iseli CE, Rosenthal EL, Caudell JJ, Spencer SA, Magnuson JS, et al. Postoperative reirradiation for mucosal head and neck squamous cell carcinomas. Arch Otolaryngol Head Neck Surg. 2009 Nov;135(11):1158-64.
97. Kasperts N, Slotman B, Leemans CR, Langendijk JA. A review on re-irradiation for recurrent and second primary head and neck cancer. Oral Oncol. 2005 Mar;41(3):225-43.
98. Smith RV, Krevitt L, Yi SM, Beitler JJ. Early wound complications in advanced head and neck cancer treated with surgery and Ir 192 brachytherapy. Laryngoscope. 2000 Jan;110(1):8-12.
99. Higginson IJ, Evans CJ. What is the evidence that palliative care teams improve outcomes for cancer patients and their families?. Cancer J. 2010 Sep-Oct;16 (5):423-35.
100. McLarnon C, Kulloo P, Mehanna H, Kelly C, Paleri V. Quality-oflife considerations in treatment of unresectable, recurrent head and neck cancer. Expert Rev Anticancer Ther. 2010 Mar;10(3):345-52.
101. Stenson KM, Kunnavakkam R, Cohen EE, Portugal LD, Blair E, Haraf DJ, et al. Chemoradiation for patients with advanced oral cavity cancer. Laryngoscope. 2010 Jan;120(1):93-9.
102. Poeta ML, Manola J, Goldwasser MA, Forastiere A, Benoit N, Califano JA, et al. TP53 mutations and survival in squamous-cell carcinoma of the head and neck. N Engl J Med. 2007 Dec 20;357 (25): 2552-61.
103. Perrone F, Bossi P, Cortelazzi B, Locati L, Quattrone P, Pierotti MA, et al. TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinoma. J Clin Oncol. 2010 Feb 10; 28 (5):761-6.
104. Chung CH, Zhang Q, Hammond EM, Trotti AM 3rd, Wang H, Spencer S, et al. Integrating epidermal growth factor receptor assay with clinical parameters improves risk classification for relapse and survival in head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2010 Aug 21 [Epub]. Doi:10.1016/j.ijrobp.2010. 05.024.
105. Bernier J, Bentzen SM, Vermorken JB. Molecular therapy in head and neck oncology. Nat Rev Clin Oncol. 2009 May;6(5):266-77.